uniQure N.V. (QURE) is a publicly traded Healthcare sector company. As of July 22, 2026, QURE trades at $40.17 with a market cap of $2.73B and a P/E ratio of -11.48. QURE moved +0.20% today. Year to date, QURE is +67.53%; over the trailing twelve months it is +176.48%. Its 52-week range spans $5.89 to $71.50. Analyst consensus is strong buy with an average price target of $66.33. Rallies surfaces QURE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
uniQure N.V. (QURE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. QURE moved +0.20% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $40.17 |
| Market Cap | $2.73B |
| P/E Ratio | -11.48 |
| EPS | $-3.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $71.50 |
| 52-Week Low | $5.89 |
| Volume | 258 |
| Avg Volume | 0 |
| Revenue (TTM) | $18.09M |
| Net Income | $-208.87M |
| Gross Margin | 90.56% |
11 analysts cover QURE: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $66.33.